Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

NCT00255463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Anastrazole
DRUG: Gefitinib

Sponsor

AstraZeneca